From: Real-world safety of ulinastatin: a post-marketing surveillance of 11,252 patients in China
Adverse drug reaction | ICU | General ward | ||
---|---|---|---|---|
patients (n) | events (n) | patients (n) | events (n) | |
Possibly related | ||||
Abnormal liver function | 3 | 3 * | 1 | 1 |
Liver function damage | 1 | 1 | 0 | 0 |
Thrombocytosis | 1 | 1 | 1 | 1 |
Thrombocytopenia | 1 | 1 | 0 | 0 |
Leukocytosis | 1 | 1 | 0 | 0 |
Rash | 1 | 1 | 0 | 0 |
Probably related | ||||
Leukopenia | 1 | 1 | 0 | 0 |
Sum | 9 | 9 | 2 | 2 |